Original Research
Published on 09 Sep 2022
Economic evaluation of margetuximab vs. trastuzumab for pretreated ERBB2-positive advanced breast cancer in the US and China
in Health Economics
- 4,337 views
- 6 citations
Original Research
Published on 09 Sep 2022
in Health Economics
Original Research
Published on 06 Aug 2021
in Health Economics
Original Research
Published on 13 Dec 2021
in Thoracic Oncology
Original Research
Published on 29 Nov 2022
in Regulatory Science
Methods
Published on 16 Apr 2019
in Volcanology
Original Research
Published on 12 Mar 2024
in Food Policy and Economics
Original Research
Published on 22 Aug 2022
in Drugs Outcomes Research and Policies
Original Research
Published on 23 Aug 2024
in Headache and Neurogenic Pain
Original Research
Published on 11 Jan 2024
in Drugs Outcomes Research and Policies
Original Research
Published on 05 Jun 2025
in Gastrointestinal Cancers: Gastric and Esophageal Cancers
Original Research
Published on 29 Sep 2023
in Health Economics
Original Research
Published on 01 May 2025
in Drugs Outcomes Research and Policies
Original Research
Published on 18 Nov 2022
in Drugs Outcomes Research and Policies
Original Research
Published on 29 Jun 2021
in Thoracic Oncology
Original Research
Published on 27 Nov 2024
in Cancer Immunity and Immunotherapy
Original Research
Published on 01 Jul 2024
in Public Health Policy